Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The Fifth World Symposium on Pulmonary Hypertension.

Literature DB >> 24355633

The Fifth World Symposium on Pulmonary Hypertension.

Nazzareno Galiè¹, Gerald Simonneau².

Abstract

Entities: Disease

Keywords: Fifth World Symposium; pulmonary arterial hypertension; pulmonary hypertension

Mesh：

Substances：
Antihypertensive Agents

Year: 2013 PMID： 24355633 DOI： 10.1016/j.jacc.2013.10.030

Source DB: PubMed Journal: J Am Coll Cardiol ISSN： 0735-1097 Impact factor: 24.094

Keyword Cloud
Cited

× No keyword cloud information.

44 in total

1. Prevalence and hospital discharge status of human immunodeficiency virus-associated pulmonary arterial hypertension in the United States.

Authors: Marshaleen Henriques-Forsythe; Srinadh Annangi; Harrison W Farber
Journal: Pulm Circ Date: 2015-09 Impact factor: 3.017

Review 2. Novel approaches to pulmonary arterial hypertension drug discovery.

Authors: Yon K Sung; Ke Yuan; Vinicio A de Jesus Perez
Journal: Expert Opin Drug Discov Date: 2016-02-27 Impact factor: 6.098

3. Hemodynamic effects of ambrisentan-tadalafil combination therapy on progressive portopulmonary hypertension.

Authors: Yu Yamashita; Ichizo Tsujino; Takahiro Sato; Asuka Yamada; Taku Watanabe; Hiroshi Ohira; Masaharu Nishimura
Journal: World J Hepatol Date: 2014-11-27

Review 4. Ambrisentan: a review of its use in pulmonary arterial hypertension.

Authors: Belinda N Rivera-Lebron; Michael G Risbano
Journal: Ther Adv Respir Dis Date: 2017-04-20 Impact factor: 4.031

5. Prevalence, Treatment, and Outcomes of Coexistent Pulmonary Hypertension and Interstitial Lung Disease in Systemic Sclerosis.

Authors: Amber Young; Dharshan Vummidi; Scott Visovatti; Kate Homer; Holly Wilhalme; Eric S White; Kevin Flaherty; Vallerie McLaughlin; Dinesh Khanna
Journal: Arthritis Rheumatol Date: 2019-06-18 Impact factor: 10.995

Review 6. Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2.

Authors: Hui-Ming Chang; Tochukwu M Okwuosa; Tiziano Scarabelli; Rohit Moudgil; Edward T H Yeh
Journal: J Am Coll Cardiol Date: 2017-11-14 Impact factor: 24.094

The Fifth World Symposium on Pulmonary Hypertension.

1. Prevalence and hospital discharge status of human immunodeficiency virus-associated pulmonary arterial hypertension in the United States.

Review 2. Novel approaches to pulmonary arterial hypertension drug discovery.

3. Hemodynamic effects of ambrisentan-tadalafil combination therapy on progressive portopulmonary hypertension.

Review 4. Ambrisentan: a review of its use in pulmonary arterial hypertension.

5. Prevalence, Treatment, and Outcomes of Coexistent Pulmonary Hypertension and Interstitial Lung Disease in Systemic Sclerosis.

Review 6. Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2.

7. Redox Biology of Peroxisome Proliferator-Activated Receptor-γ in Pulmonary Hypertension.

8. Platelets from pulmonary hypertension patients show increased mitochondrial reserve capacity.

Review 9. Significance of main pulmonary artery dilation on imaging studies.

10. Is Anticoagulation Beneficial in Pulmonary Arterial Hypertension?